Insights into the Impact, Therapeutic Strategies, and Emerging Options in Uncomplicated UTI

Faculty

Neil J. Kocher, MD, FPMRS
Moderator
Urogynecology and Reconstructive Pelvic Surgeon
Premier Medical Group - Urology Division
Poughkeepsie, NY
Catriona Anderson, MBChB, BSc (HON), MRCGP, DFSRH
Family Medicine Physician 
Women's Health Lead, Longton Hall Surgery, NHS Primary Care Centre 
Staffordshire, England 
Medical Director, Focus Medical Clinic 
Newcastle-under-Lyme, England 
Medical Director, Focus Medical Diagnostics 
Newcastle-under-Lyme, England 
Medical Director - Stone Medical Clinic 
Stone, Staffordshire, England   
Catriona Anderson, MBChB, BSc (HON), MRCGP, DFSRH

Family Medicine Physician 

Women’s Health Lead, Longton Hall Surgery, NHS Primary Care Centre 

Staffordshire, England 

Medical Director, Focus Medical Clinic 

Newcastle-under-Lyme, England 

Medical Director, Focus Medical Diagnostics 

Newcastle-under-Lyme, England 

Medical Director – Stone Medical Clinic 

Stone, Staffordshire, England   

Paula Cobb, MPT
Patient Advocate
On Facebook: "Long-Term Antibiotic Support for Chronic/Embedded UTI" and "CHRONIC UTI - Sharing our Journey"

Statement of Need

Uncomplicated UTIs (uUTIs) are the most common indication for antibiotic prescriptions in the outpatient setting, with a lifetime incidence of 50%-60% in adult women and 20% in adult men.  uUTIs, despite their commonality, cause significant physical and psychological distress, especially when the patient experiences persistent symptoms, emphasizing the importance for health care practitioners (HCPs) to understand the impact of uUTIs through a lens of patient burden, impact on patient quality of life (QoL), the unique patient risk factors for uUTI, and the implications of treatment failure.  HCPs must manage patients while also practicing good antibiotic stewardship, so as to avoid the occurrence of bacterial drug resistance.

In this CME Outfitters webcast, expert faculty will educate learners on the emerging therapies that may improve empiric management of their patients with uUTI, as well as developing strategies to manage individual patient needs, while practicing good antibiotic stewardship.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Identify the impact of uUTI on patients and the health care system, considering burden, patient QoL, risk factors, and implications of treatment failure
  • Differentiate the types of UTIs, including uUTI, through definitions, classifications, and current evidence-based guidelines for diagnosis and management
  • Evaluate current and emerging therapies for the therapeutic management of uUTI while considering health care disparities

Financial Support

This educational activity is supported by an independent medical education grant from GSK.

Target Audience

Primary care physicians specializing in urology, infectious disease, emergency medicine, and gynecology, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours (0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-24-049-H01-P).

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.

Physician Assistants (AAPA): 1.00

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 09/16/2025. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Dr. Kocher reports no financial relationships to disclose.

Dr. Anderson reports the following financial relationships:

Advisory Board: Besins Healthcare; National Institute for Health and Care Excellence (NICE); and Viatris Inc.

Ms. Cobb reports no financial relationships to disclose.
The following individuals have no financial relationships to disclose: 

Rebecca Vargas-Jackson, MD  (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Evan Luberger (Planning Committee)
David Modrak, PhD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WCV-085-091125-06

Insights into the Impact, Therapeutic Strategies, and Emerging Options in Uncomplicated UTI
Event Date: 09/16/2024